$3.8 M Montreal-based pediatric cancer program announced by the Canadian Cancer Society and the Cole Foundation

08 May 2018

25 researchers – 7 cutting edge projects –

6 research centres - 1 goal: make Montreal the country’s excellence centre

in childhood and early adulthood leukemia and lymphoma research

Montreal, May 8, 2018 – The Canadian Cancer Society (CCS) announced this morning that $3.8 M would be invested in a Montreal-based Canadian Cancer Society/Cole Foundation Research Program that will fund childhood and early adulthood leukemia and lymphoma research. The project will position Montreal and the Province of Quebec as pediatric cancer hubs for leukemia and lymphoma account for more than 40% of childhood cancer cases diagnosed every year in Canada.

In all, seven innovative research projects will be funded by 2021. The program will support the efforts of 25 researchers, including 21 Montreal-based researchers affiliated with six major Montreal establishments (the other four are from Quebec City, Toronto and Vancouver).

“The Canadian Cancer Society invests more in pediatric cancer research than any other community organization in the country. It invested $1.5 M into this project and the Cole Foundation contributed $650,000. The remaining $1.65 M came from donors, private funders, funding agencies, hospitals and universities,” explained Suzanne Dubois, Executive Director of the CCS–Quebec. Our duo became a very lucrative trio which, to use a hockey metaphor, will help us score a lot more goals... and maybe even win the cup!

In 2015, the Cole Foundation contacted the CCS to see if they could work together to make Montreal Canada’s excellence centre in childhood and early adulthood leukemia and lymphoma research. The partnership also sought to attract other investors in order to raise nearly twice the amount that the CCS and the Cole Foundation had expected to jointly invest in the project.

The strengths of Montreal’s pediatric cancer research activities

Montreal is distinguished by a great many hematology researchers whose expertise in this area is highly focused and recognized. Unfortunately, hospital research centres often work in isolation. In addition to creating a more innovative funding mechanism, the Canadian Cancer Society/Cole Foundation Research Program sought to break down barriers and foster closer collaboration between research establishments in order to maximize resources.

“The Canadian Cancer Society/Cole Foundation Research Program will showcase the strengths of our pediatric cancer research activities and serve as a catalyst to attract even more research dollars to Montreal,” said Barry Cole, President and Board Chair of the Cole Foundation. The Cole Foundation’s goal is to make Montreal the country’s top pediatric cancer research centre for leukemia and lymphoma, and I’m pleased to say that this morning’s announcement brings us closer to this goal.”

The Program will foster greater synergy between establishments dedicated to research, training new research teams, and developing new ideas. Another unique aspect of the program is that the seven funded projects will include the involvement of clinicians (treating physicians).

Names of the six Montreal establishments where the projects funded by the Canadian Cancer Society/Cole Foundation Research Program will take place:

  • The CHU Sainte-Justine
  • The Goodman Cancer Research Centre(CRCG)
  • The Hôpital Maisonneuve-Rosemont
  • The Institute for Research in Immunology and Cancer (IRIC)
  • The Jewish General Hospital
  • The Montreal Clinical Research Institute (IRCM)

Names of Canadian Cancer Society/Cole Foundation Research Program investors

  • The Birks Family Foundation
  • The Maryse and William Brock Chair
  • The CHU Sainte-Justine Foundation
  • The Drummond Foundation
  • The Fonds de recherche du Québec - Santé (FRQS)
  • The Morris and Rosalind Goodman Family Foundation
  • The Henry and Berenice Kaufmann Foundation
  • The David Laidley Foundation
  • The Letko Brosseau-WCPD Foundation
  • The Molson Foundation
  • The Montreal Children's Hopistal Foundation
  • Power Corporation
  • The Mirella and Lion Saputo Foundation
  • The Trottier Family Foundation
  • The Université de Montréal
  • The R. Howard Webster Foundation
  • The Zeller Family Foundation

More information about the program and the expertise

Canadian Cancer Society/Cole Foundation Research Program

Montreal: excellence centre in pediatric cancer research

About the Cole Foundation

The Cole Foundation offers research grants to clinicians, postdoctoral scientists and postgraduate students and young principal investigators who are conducting research on leukemia and lymphoma and other related diseases in children and young adults. Through grants, the Cole Foundation has given more than $12 million to hospital researchers and laboratories in the Greater Montreal in the past 8 years. The late John N. (Jack) Cole created the Foundation in 1980 to support pediatric hematology and oncology research in Montreal. The businessman has funded the Penny Cole Laboratory of the Montreal Children’s Hospital and the Jack Cole Chair in Pediatric Hematology/Oncology at McGill University. 

About the Canadian Cancer Society With the support of 300,000 donors annually and 30,000 volunteers, the Canadian Cancer Society (CCS) is the Quebec cancer organization with the greatest potential to save more lives. Over two million Quebecers turn to us for help each and every year. The money raised by the CCS helps:

  • Prevent more cancers and demand laws that protect public health
  • Fund more research projects
  • Support more people living with cancer

Visit cancer.ca or call us at 1 888 939-3333.



Lauriane Ayivi

Communications and Public Relations Coordinator

Canadian Cancer Society – Quebec


514 255-5151, Ext. 22417